451 related articles for article (PubMed ID: 21060015)
1. Functional impact of white matter hyperintensities in cognitively normal elderly subjects.
Murray ME; Senjem ML; Petersen RC; Hollman JH; Preboske GM; Weigand SD; Knopman DS; Ferman TJ; Dickson DW; Jack CR
Arch Neurol; 2010 Nov; 67(11):1379-85. PubMed ID: 21060015
[TBL] [Abstract][Full Text] [Related]
2. Correlations between MRI white matter lesion location and executive function and episodic memory.
Smith EE; Salat DH; Jeng J; McCreary CR; Fischl B; Schmahmann JD; Dickerson BC; Viswanathan A; Albert MS; Blacker D; Greenberg SM
Neurology; 2011 Apr; 76(17):1492-9. PubMed ID: 21518999
[TBL] [Abstract][Full Text] [Related]
3. White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative.
Carvalho de Abreu DC; Pieruccini-Faria F; Sarquis-Adamson Y; Black A; Fraser J; Van Ooteghem K; Cornish B; Grimes D; Jog M; Masellis M; Steeves T; Nanayakkara N; Ramirez J; Scott C; Holmes M; Ozzoude M; Berezuk C; Symons S; Mohammad Hassan Haddad S; Arnott SR; Binns M; Strother S; Beaton D; Sunderland K; Theyers A; Tan B; Zamyadi M; Levine B; Orange JB; Roberts AC; Lou W; Sujanthan S; Breen DP; Marras C; Kwan D; Adamo S; Peltsch A; Troyer AK; Black SE; McLaughlin PM; Lang AE; McIlroy W; Bartha R; ; Montero-Odasso M
Eur J Neurol; 2023 Apr; 30(4):920-933. PubMed ID: 36692250
[TBL] [Abstract][Full Text] [Related]
4. Regional white matter hyperintensities in normal aging, single domain amnestic mild cognitive impairment, and mild Alzheimer's disease.
Kim JH; Hwang KJ; Kim JH; Lee YH; Rhee HY; Park KC
J Clin Neurosci; 2011 Aug; 18(8):1101-6. PubMed ID: 21723730
[TBL] [Abstract][Full Text] [Related]
5. White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease.
Dalaker TO; Larsen JP; Dwyer MG; Aarsland D; Beyer MK; Alves G; Bronnick K; Tysnes OB; Zivadinov R
Neuroimage; 2009 Oct; 47(4):2083-9. PubMed ID: 19539037
[TBL] [Abstract][Full Text] [Related]
6. Effects of white matter hyperintensities distribution and clustering on late-life cognitive impairment.
Jiménez-Balado J; Corlier F; Habeck C; Stern Y; Eich T
Sci Rep; 2022 Feb; 12(1):1955. PubMed ID: 35121804
[TBL] [Abstract][Full Text] [Related]
7. Cross-sectional and longitudinal associations between total and regional white matter hyperintensity volume and cognitive and motor function in Parkinson's disease.
Pozorski V; Oh JM; Okonkwo O; Krislov S; Barzgari A; Theisen F; Sojkova J; Bendlin BB; Johnson SC; Gallagher CL
Neuroimage Clin; 2019; 23():101870. PubMed ID: 31150958
[TBL] [Abstract][Full Text] [Related]
8. Differential Effects of Confluent and Nonconfluent White Matter Hyperintensities on Functional Connectivity in Mild Cognitive Impairment.
Kumar D; Vipin A; Wong B; Ng KP; Kandiah N
Brain Connect; 2020 Dec; 10(10):547-554. PubMed ID: 33050714
[No Abstract] [Full Text] [Related]
9. Impact of regional white matter hyperintensities on specific gait function in Alzheimer's disease and mild cognitive impairment.
Ogama N; Endo H; Satake S; Niida S; Arai H; Sakurai T
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):2045-2055. PubMed ID: 34585518
[TBL] [Abstract][Full Text] [Related]
10. Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging.
Gootjes L; Teipel SJ; Zebuhr Y; Schwarz R; Leinsinger G; Scheltens P; Möller HJ; Hampel H
Dement Geriatr Cogn Disord; 2004; 18(2):180-8. PubMed ID: 15211074
[TBL] [Abstract][Full Text] [Related]
11. White matter microstructural integrity and cognitive function in a general elderly population.
Vernooij MW; Ikram MA; Vrooman HA; Wielopolski PA; Krestin GP; Hofman A; Niessen WJ; Van der Lugt A; Breteler MM
Arch Gen Psychiatry; 2009 May; 66(5):545-53. PubMed ID: 19414714
[TBL] [Abstract][Full Text] [Related]
12. Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline.
Silbert LC; Nelson C; Howieson DB; Moore MM; Kaye JA
Neurology; 2008 Jul; 71(2):108-13. PubMed ID: 18606964
[TBL] [Abstract][Full Text] [Related]
13. Lesion location matters: The relationships between white matter hyperintensities on cognition in the healthy elderly.
Lampe L; Kharabian-Masouleh S; Kynast J; Arelin K; Steele CJ; Löffler M; Witte AV; Schroeter ML; Villringer A; Bazin PL
J Cereb Blood Flow Metab; 2019 Jan; 39(1):36-43. PubMed ID: 29106319
[TBL] [Abstract][Full Text] [Related]
14. Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals.
Brugulat-Serrat A; Salvadó G; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Sánchez-Benavides G; Gramunt N; Fauria K; Cardoso MJ; Barkhof F; Molinuevo JL; Gispert JD;
Brain Imaging Behav; 2020 Oct; 14(5):2012-2023. PubMed ID: 31278650
[TBL] [Abstract][Full Text] [Related]
15. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
[TBL] [Abstract][Full Text] [Related]
16. Effect of BDNF Val66Met polymorphism on regional white matter hyperintensities and cognitive function in elderly males without dementia.
Huang CC; Liu ME; Chou KH; Yang AC; Hung CC; Hong CJ; Tsai SJ; Lin CP
Psychoneuroendocrinology; 2014 Jan; 39():94-103. PubMed ID: 24275008
[TBL] [Abstract][Full Text] [Related]
17. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
[TBL] [Abstract][Full Text] [Related]
18. Coevolution of white matter hyperintensities and cognition in the elderly.
Maillard P; Carmichael O; Fletcher E; Reed B; Mungas D; DeCarli C
Neurology; 2012 Jul; 79(5):442-8. PubMed ID: 22815562
[TBL] [Abstract][Full Text] [Related]
19. Association of white matter hyperintensities and gray matter volume with cognition in older individuals without cognitive impairment.
Arvanitakis Z; Fleischman DA; Arfanakis K; Leurgans SE; Barnes LL; Bennett DA
Brain Struct Funct; 2016 May; 221(4):2135-46. PubMed ID: 25833685
[TBL] [Abstract][Full Text] [Related]
20. Cognitive and anatomic contributions of metabolic decline in Alzheimer disease and cerebrovascular disease.
Kuczynski B; Reed B; Mungas D; Weiner M; Chui HC; Jagust W
Arch Neurol; 2008 May; 65(5):650-5. PubMed ID: 18474742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
